Most Americans aren't anti-vaccine. They're uncertain — and that's a growing public health challenge

2 days ago

BioMarin to acquire Alesta Therapeutics for $275 million

2 days ago

Cancer vaccine from Moderna, Merck shows promise in late-stage trial; both stocks soar

4 days ago

Hims & Hers CEO says FTC lawsuit misunderstands how the company works

5 days ago

The startup using AI to help rare disease families develop custom treatments

5 days ago

Court rules companies can't import Gilead medications from overseas

5 days ago

Novo Nordisk CEO defends lawsuit against Eli Lilly: 'Competition has to be fair'

10 days ago

Trump administration ends Medicaid, CHIP funding for gender-affirming care for children

12 days ago

We're lifting our price target on Cardinal Health after issuing rosy profit guidance

12 days ago

Trump wants to split the MMR vaccine. Experts say that's unlikely

12 days ago

Jazz Pharmaceuticals to buy Actio Biosciences for $820 million

12 days ago

Eli Lilly takes weight-loss pill battle global

12 days ago

Trump signs order calling for fewer childhood vaccines, falsely linking shots to autism

12 days ago

New genetic tests are catching rare diseases before symptoms start

13 days ago

Why we like Boeing's latest deal — plus, what to expect from this health stock

13 days ago

Hunter Biden says Joe Biden's cancer has spread further, 'very painful'

13 days ago

Cyclospora fears lead consumers to lose their appetite for salads

15 days ago

Jim Cramer highlights 5 investing themes — and the stocks to buy for each

16 days ago

Sen. Mitch McConnell says he's left rehab, will work from home

17 days ago

CAMP4 advances rare disease treatment for SYNGAP1 into human trials

17 days ago

Divide between Eli Lilly and Novo Nordisk is widening after latest earnings

17 days ago

AstraZeneca may buck a decade of pharma strategy to buy U.S. scale

17 days ago

This stock is more than a way to play GLP-1 boom

17 days ago

Bank of America spends $250M a year on GLP-1 drugs for its employees, CEO says

18 days ago

Eli Lilly blows past estimates, raises outlook on Zepbound and Mounjaro sales

18 days ago

CVS blows past estimates, hikes guidance as insurance unit continues to improve

18 days ago

Novo CEO defends economics of Wegovy pill as lower prices weigh on sales

18 days ago

Chipotle stock falls on potential link to salmonella outbreak in Minnesota

19 days ago

Novo Nordisk shares slide after guidance disappoints investors

19 days ago

P&G will acquire supplements brand Thorne for $3.8 billion, CEO tells CNBC

19 days ago

Pfizer tops estimates, hikes low end of revenue guidance on non-Covid products

19 days ago

Merck hikes revenue outlook as new drug sales grow, but cuts profit guidance

19 days ago